glp-1 gip medications muscle loss comparison Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational only—these are Mitigating loss of lean muscle

They can also cause weight gain

This group creates the largest care pathway because chronic weight management needs repeated clinical review

Do not use if the solution shows discoloration or particulate matter

Wang IJ et al

IGF-1 - The Growth Factor of Healing and Rejuvenation By Lisa Wells, RN IGF-1 (Insulin-like Growth Factor-1), also known as Somatomedin C is a 70 amino acid protein that is produced mainly in the liver in response to human growth hormone (HGH or GH)

Management of Hyperglycemia in Type 2 Diabetes, A consensus report by the american diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)